What a Biden Administration Might Portend for Regulation of Laboratory Developed Tests by Glenn S. Demby | Nov 17, 2020 | Articles, Essential, FDA-nir, National Lab Reporter... This content is for Paid Members only.RegisterAlready a member? Log in here
Agency Temporarily Allows Modifications of Influenza and RSV Tests Without Premarket Notification by Glenn S. Demby | Nov 3, 2020 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, FDA-dtet... This content is for Paid Members only.RegisterAlready a member? Log in here
FDA Pulls the Plug on EUA Review of Laboratory Developed Tests for COVID-19 by Glenn S. Demby | Nov 2, 2020 | Articles, Clinical Diagnostics Insider, Coronavirus, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet, FDA-dtet... This content is for Paid Members only.RegisterAlready a member? Log in here
FDA Pulls the Plug on EUA Review of COVID-19 LDTs by Glenn S. Demby | Nov 2, 2020 | Articles, Essential, FDA-lca, Lab Compliance Advisor... This content is for Paid Members only.RegisterAlready a member? Log in here
Market for LDTs Expected to Top $17 Billion by 2025 by Glenn S. Demby | Oct 29, 2020 | Articles, Essential, Industry Buzz-lir, Laboratory Industry Report... This content is for Paid Members only.RegisterAlready a member? Log in here